Vasopharm

克理索療法是一家生物製藥公司。它關注小說的發展,非甾體抗炎藥物,稱為多功能抗炎藥。發展和獨占鼇頭藥物過敏、呼吸道、皮膚科、眼科、肺和胃腸道炎性疾病。這是原名Morria生物製藥。它成立於2005年,總部設在倫敦,英國。

安比拉神經病治療是臨床階段製藥公司開發治療潛在治療一係列上癮位於大波士頓,MA區域。

Indena是一家致力於識別、開發和生產的活動原則來源於植物,用於製藥、保健食品和化妝品行業。Indena、民營意大利公司約有700名員工,其中包括10%致力於全職研究,旨在培養管理,製造、分銷業務在全世界40多個國家。Indena成功的關鍵是它的研究,包括:藥用植物的藥理篩選的好處;識別新的活躍的原則;提取和純化係統的開發和工業應用的前沿。phyto-chemical研究進行Indena Settala自己的研究中心,意大利。Indena同樣也與世界上最著名的大學和私人研究機構在生物的安全性和有效性臨床評估階段i的主要戰略目標之一的醫藥研究開發新的積極的原則的應用程序。這也是一個不可缺少的保健食品和化妝品行業的基礎。在製藥行業Indena目前專注於抗癌治療的發展,紫杉醇的成功後,以及在抗菌和抗病毒藥物。還在研究是活躍的原則治療病態和中樞神經係統功能障礙,如抑鬱,焦慮,陽痿,睡眠障礙、感覺過敏。 Today Indena is also concentrating its efforts on the industrial production of high-quality standardised active principles derived from plants, which are important ingredients in health food products. In fact, the company produces standardised extracts from edible plants that are traditionally recognised as having therapeutic properties, as well as from plants that have proven pharmacological value. Indena's research and production activities are particularly attentive to plant-based principles that have anti-oxidant properties and are effective in preventing damage caused by free radicals. Backed by over 80 years of botanical experience, the Italian company has developed a plantation network, managed by experts, to supply its research and production centers with officinal plants, while at the same time ensuring bio-diversity and protecting the ecosystem balance from uncontrolled harvesting. Today more than 60% of the raw material used in the manufacturing process comes from cultivation. Indena's decades-long global presence in the plant extraction industry is a guarantee of its in-depth knowledge and understanding of the business, market trends and legal considerations, through constant communication and interaction between the company's experts and the major international regulatory authorities such as WHO, EMEA, and ESCOP, and main pharmacopoeias.

Neuraltus製藥是一家民營生物製藥公司,致力於開發和商業化創新療法,解決關鍵的未滿足的需求對病人和醫生在神經退行性疾病的治療。公司與全球合作ALS專家和尋求輸入病人倡導組織幫助通知臨床發展道路和更好地理解需求的人受到疾病的影響。

JADO旨在成為領袖筏幹預治療的新興領域,通過與潛在的醫藥產品的開發治療人類疾病。木筏是細胞膜的論文,在關鍵的生物學途徑發揮不可或缺的作用。利用其藥物開發平台,叫做筏幹預技術,JADO是利用新見解和理解細胞膜的化學和組織,旨在使我們解決難以治療的疾病,比如過敏(特應性皮炎、哮喘),病毒和細菌感染,癌症,神經退行性疾病(老年癡呆症)和代謝疾病(糖尿病、脂質存儲疾病)。

神諭的艾滋病毒診斷旨在提供一個完整的套件,從簡單的病毒載量檢測到先進的基因檢測,醫藥組織和臨床醫生。神諭的的一些內部測試和開發。作為MMC的投資的一部分,利物浦大學的治療藥物監測服務,“˜紡”業務。